Profile of:

Francesco Caso


Prof. Dr. Francesco Caso, MD, PhD, MSc, is Associate Professor of Rheumatology at the Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy, and holds the Italian National Scientific Qualification for Full Professorship in Hematology, Oncology and Rheumatology. He is Coordinator of the Tutorship Programme and Educational Activities of the Postgraduate School of Rheumatology at the University of Naples Federico II and a member of the Faculty Board of the PhD Programme in Advanced Biomedical and Surgical Therapies. He also serves as Scientific Lead for Clinical Research at Immunopharmalab, Department of Pharmacy, University of Naples Federico II. Prof. Caso completed his specialization in Rheumatology cum laude at the University of Naples Federico II and subsequently obtained a PhD in Medical, Clinical and Experimental Sciences at the University of Padua, with additional research training at the University of Siena. He also holds a Level II Master’s Degree in Translational Research in Rheumatology, cum laude, from the University of Trieste, a Level II Master’s Degree in Healthcare Management, and advanced postgraduate training in immune-mediated diseases. His main research interests include psoriatic arthritis, spondyloarthritis, autoinflammatory diseases, and the pathogenetic mechanisms underlying autoimmune and immune-mediated rheumatic diseases, with particular interest in translational research and clinical phenotyping. He is author or co-author of more than 230 peer-reviewed scientific publications and is actively involved in national and international rheumatology research networks. He is an Associate Member of the Assessment of SpondyloArthritis international Society (ASAS) and a member of OMERACT, GRAPPA, EULAR, the Italian Society of Rheumatology (SIR), and the Scientific Committee of GIRRCS.

Full name: Francesco Caso

Current country: Italy

Membership level: Associate

Type of membership: Member

Number of publications: 9

The at-risk-to-early continuum of enteropathic spondyloarthritis (2026)
https://pubmed.ncbi.nlm.nih.gov/42330993/

Virus-induced sacroiliitis: parvovirus B19 expands the spectrum of spondyloarthritis-like phenotypes (2026)
https://pubmed.ncbi.nlm.nih.gov/42370507/

Proposal for a disease severity score for axial spondyloarthritis: results from an Italian longitudinal study (2025)
https://pubmed.ncbi.nlm.nih.gov/40737054/

Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study (2024)
https://pubmed.ncbi.nlm.nih.gov/39294672/

The Effects of Smoking, Alcohol, and Dietary Habits on the Progression and Management of Spondyloarthritis (2024)
https://pubmed.ncbi.nlm.nih.gov/39728027/

Role of Patrick-FABER test in detecting sacroiliitis and diagnosing spondyloarthritis in subjects with low back pain (2023)
https://pubmed.ncbi.nlm.nih.gov/37650318/

The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis (2023)
https://pubmed.ncbi.nlm.nih.gov/37083177/

The Patrick-FABER test in detecting active sacroiliitis in spondyloarthritis patients: a prospective study using magnetic resonance as reference standard (2022)
https://pubmed.ncbi.nlm.nih.gov/35349407/

Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/35525861/